Evidence map›Paper›PMID 36221085›Full record

ArticleBMC psychiatry2022

Mainstreaming adult ADHD into primary care in the UK: guidance, practice, and best practice recommendations.

Philip Asherson, Laurence Leaver, Marios Adamou, Muhammad Arif, Gemma Askey, Margi Butler, Sally Cubbin, Tamsin Newlove-Delgado, James Kustow, Jonathan Lanham-Cook and 8 more

Open access · goldAbstract read
In one paragraph

Article in BMC psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
8.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Attention-deficit/hyperactivity disorder (ADHD) in adults: evidence base, uncertainties and controversies.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2025
    Article
  11. Article
  12. ADHD: overdiagnosis or opportunity?The British journal of general practice : the journal of the Royal College of General Practitioners · 2025
    Article
  13. Improving healthcare information for young people with ADHD in general practice: a qualitative study.The British journal of general practice : the journal of the Royal College of General Practitioners · 2025
    Article
  14. Article
  15. Article
  16. A guide for primary care clinicians managing ADHD medication side effects.The British journal of general practice : the journal of the Royal College of General Practitioners · 2025
    Article
  17. Co-Producing Resources to Help Improve Access to Primary Care for Young People With Attention Deficit Hyperactivity Disorder.Health expectations : an international journal of public participation in health care and health policy · 2025
    Article
  18. Article
  19. Diagnosing ADHD in adults in randomized controlled studies: a scoping review.European psychiatry : the journal of the Association of European Psychiatrists · 2025
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 9 institutions in 1 country.

Philip AshersonSocial Genetic and Developmental Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, Kings College London, De Crespigny Park, London, SE5 8AF, UK. philip.asherson@kcl.ac.uk.
Laurence LeaverGreen Templeton College, Oxford, UK.
Marios AdamouUniversity of Huddersfield, Huddersfield, UK.
Muhammad ArifLeicestershire Partnership NHS Trust, Leicester, UK.
Gemma AskeyNHS Warrington Clinical Commissioning Group, Warrington, UK.
Margi ButlerNHS Warrington Clinical Commissioning Group, Warrington, UK.
Sally CubbinManor Hospital, Oxford, UK.
Tamsin Newlove-DelgadoUniversity of Exeter, Exeter, UK.
James KustowBarnet, Enfield and Haringey Mental Health NHS Trust, London, UK.
Jonathan Lanham-CookWarrington Primary Care Community Interest Company, Warrington, UK.
James FindlayNHS Northamptonshire Clinical Commissioning Group, Northampton, UK.
Judith MaxwellInclusion Health Care, Leicester, UK.
Peter MasonADHD And Psychiatry Services Limited, Liverpool, UK.
Helen ReadOxleas Foundation Trust, London, UK.
Kobus van RensburgNorthamptonshire Healthcare NHS Foundation Trust, Kettering, UK.
Ulrich Müller-SedgwickBarnet, Enfield and Haringey Mental Health NHS Trust, London, UK.
Jane Sedgwick-MüllerSocial Genetic and Developmental Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, Kings College London, De Crespigny Park, London, SE5 8AF, UK.
Caroline SkirrowNovoic Ltd, London, UK.
Barnet Enfield and Haringey Mental Health Trust · GBBristol Clinical Commissioning Group · GBKing's College London · GBNorthamptonshire Healthcare NHS Foundation Trust · GBLeicestershire Partnership NHS Trust · GBManor Hospital · GBOxleas NHS Foundation Trust · GBUniversity of Exeter · GBUniversity of Huddersfield · GB

Funding

Department of Health
6 · The paper itself

Abstract

backgroundADHD in adults is a common and debilitating neurodevelopmental mental health condition. Yet, diagnosis, clinical management and monitoring are frequently constrained by scarce resources, low capacity in specialist services and limited awareness or training in both primary and secondary care. As a result, many people with ADHD experience serious barriers in accessing the care they need.

methodsProfessionals across primary, secondary, and tertiary care met to discuss adult ADHD clinical care in the United Kingdom. Discussions identified constraints in service provision, and service delivery models with potential to improve healthcare access and delivery. The group aimed to provide a roadmap for improving access to ADHD treatment, identifying avenues for improving provision under current constraints, and innovating provision in the longer-term. National Institute for Health and Care Excellence (NICE) guidelines were used as a benchmark in discussions.

resultsThe group identified three interrelated constraints. First, inconsistent interpretation of what constitutes a 'specialist' in the context of delivering ADHD care. Second, restriction of service delivery to limited capacity secondary or tertiary care services. Third, financial limitations or conflicts which reduce capacity and render transfer of care between healthcare sectors difficult. The group recommended the development of ADHD specialism within primary care, along with the transfer of routine and straightforward treatment monitoring to primary care services. Longer term, ADHD care pathways should be brought into line with those for other common mental health disorders, including treatment initiation by appropriately qualified clinicians in primary care, and referral to secondary mental health or tertiary services for more complex cases. Long-term plans in the NHS for more joined up and flexible provision, using a primary care network approach, could invest in developing shared ADHD specialist resources.

conclusionsThe relegation of adult ADHD diagnosis, treatment and monitoring to specialist tertiary and secondary services is at odds with its high prevalence and chronic course. To enable the cost-effective and at-scale access to ADHD treatment that is needed, general adult mental health and primary care must be empowered to play a key role in the delivery of quality services for adults with ADHD.

Indexed as

Attention Deficit Disorder with HyperactivityAdultHealth Services AccessibilityHumansPrimary Health CareReferral and ConsultationUnited KingdomAdultAttention deficit disorder with hyperactivityContinuity of patient care, service delivery, National Institute of health and care excellence (NICE)Delivery of healthcareDelivery of health care, integratedPrimary health careSecondary careTertiary healthcareUK adult ADHD network (UKAAN)

Identifiers

PMID36221085
PMCPMC9553294
OpenAlexW4304471530

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.